Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Receptor BioLogix, Inc.

Receptor BioLogix, Inc. is a biopharmaceutical company focused on developing the first broad-spectrum anti-HER therapeutic, resulting from its program to commercialize a newly discovered class of protein therapeutics called Intron Fusion Proteins™ (IFP™) to treat cancer, autoimmune, metabolic and other diseases.


Contact Details:
1140 Veterans Boulevard, Suite A
South San Francisco
California
94080
United States of America
Tel: (650) 266-4600
Fax:(650) 952-2205
Email:info@rblx.com
WWW:

www.receptorbiologix.com/




Loading...

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 350 times since April 2007, the link to the organisation's website has been followed 65 times

Recent Search Terms used to find this page: Receptor Biologix Inc. | receptor biologix inc | Receptor Biologix, Inc. | Receptor Biologix, Inc. | Receptor BioLogix Inc. | Receptor Biologix., Inc. | .

Search for more companies in South San Francisco

Search for more companies in California



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Receptor BioLogix, Inc.

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.